Literature DB >> 6804145

Estrogen receptors in 7,12-dimethylbenz (a) anthracene (DMBA) induced pancreatic carcinoma in rats and in human pancreatic carcinoma.

K Satake, T Yoshimoto, R Mukai, K Umeyama.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6804145

Source DB:  PubMed          Journal:  Clin Oncol        ISSN： 0305-7399


× No keyword cloud information.
  9 in total

Review 1.  Treatment of pancreatic cancer. Promises and problems of tamoxifen, somatostatin analogs, and gemcitabine.

Authors:  L Rosenberg
Journal:  Int J Pancreatol       Date:  1997-10

Review 2.  Pancreatic cancer: a review of emerging therapies.

Authors:  L Rosenberg
Journal:  Drugs       Date:  2000-05       Impact factor: 9.546

3.  Cytosolic estrogen and progesterone receptors in exocrine pancreatic adenocarcinoma.

Authors:  C Mao; D Desaty; J M Howard
Journal:  Int J Pancreatol       Date:  1994-04

4.  Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones.

Authors:  T W Redding; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

Review 5.  Biology of pancreatic cancer.

Authors:  G J Poston; J Gillespie; P J Guillou
Journal:  Gut       Date:  1991-07       Impact factor: 23.059

6.  Oophorectomy has no effect on experimental pancreatic carcinogenesis in the Syrian hamster.

Authors:  J F Chester; R I Nicholson; J V Lever; A R Turnbull; D C Britton
Journal:  Br J Cancer       Date:  1989-05       Impact factor: 7.640

7.  A prospective randomised controlled trial of tamoxifen and cyproterone acetate in pancreatic carcinoma.

Authors:  J J Keating; P J Johnson; A M Cochrane; B G Gazzard; N Krasner; P M Smith; P N Trewby; P Wheeler; S P Wilkinson; R Williams
Journal:  Br J Cancer       Date:  1989-11       Impact factor: 7.640

8.  Classical oestrogen receptor is not detectable in pancreatic adenocarcinoma.

Authors:  O M Taylor; J Teasdale; P N Cowen; M J McMahon; E A Benson
Journal:  Br J Cancer       Date:  1992-09       Impact factor: 7.640

9.  R269C variant of ESR1: high prevalence and differential function in a subset of pancreatic cancers.

Authors:  Tomer Boldes; Keren Merenbakh-Lamin; Shani Journo; Eliya Shachar; Doron Lipson; Adva Yeheskel; Metsada Pasmanik-Chor; Tami Rubinek; Ido Wolf
Journal:  BMC Cancer       Date:  2020-06-08       Impact factor: 4.430
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.